LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | $53.49M | $42.16M | $35.36M | $34.46M | $26.38M | $30.53M | $24.39M |
| Cost of Revenue | $27.64M | $21.06M | $15.40M | $16.63M | $12.31M | $17.30M | $14.78M |
| Gross Profit | $25.85M | $21.11M | $19.95M | $17.83M | $14.07M | $13.23M | $9.61M |
| Gross Margin | 48.33% | 50.06% | 56.44% | 51.75% | 53.35% | 43.33% | 39.41% |
| Operating Expenses | $36.52M | $33.34M | $40.13M | $37.48M | $32.58M | $25.94M | $18.93M |
| Operating Income | $-10.66M | $-12.23M | $-20.18M | $-19.65M | $-18.50M | $-12.71M | $-9.32M |
| Operating Margin | -19.94% | -29.00% | -57.06% | -57.03% | -70.13% | -41.65% | -38.20% |
| Net Income | $-31.40M | $-14.38M | $-19.91M | $-19.60M | $-19.77M | $-14.66M | $-12.59M |
| Net Margin | -58.71% | -34.11% | -56.32% | -56.88% | -74.95% | -48.01% | -51.64% |
| EPS (Basic) | $-2.73 | $-1.31 | $-1.96 | $-2.10 | $-1.81 | $-1.57 | $-11.77 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A | N/A |